HemorrhoidsNCT07878546
Ligasure Versus Conventional Diathermy in Hemorrhoidectomy
A study testing ligasure in people with Hemorrhoids, run by Sohag University at 1 site in Egypt.
Trial summary
comparison study in the treatment of hemorrhoid between ligasure device and the conventional diathermy Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Hemorrhoids
- What is being tested?
- ligasure
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteEgypt
- Study dates
- 25 Sep 2026to 25 Apr 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- all patients with symptomatic hemorrhoid require hemorrhoidectomy
Who cannot join
- presence of other rectal or anal pathology, patients with recurrent hemorrhoid, patients with other medcal or anasthetic contraindications
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
mphamed refaey, master contact
Egypt1 site, 1 recruiting
- Recruiting
Mohamd Refaey Mohamed
Sohag
mohamed refaey, master, 01126544564, drmido2025@gmail.com
About this study
comparison study in the treatment of hemorrhoid between ligasure device and the conventional diathermy
Read the detailed description
comparison study between ligasure and conventional diathermy in hemorroidectomy regarding the duration of postoperatine pain, intraoperative and postoperative bleeding, early return to work, postoperative itching, and return to the normal life.
this prospective study will be conducted on 40 patients diagnosed with hemorroidectomy including all patients with symptomatic hemorrhoid comparing two groups the first group undergo hemorrhoidectomy using ligasure the second group using conventional diathermy
- Conditions
- Hemorrhoids
- Being tested
- ligasure
- Keywords
- ligasure
- Medical subject headings
- Hemorrhoids
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ligasureDevice
using the ligasure devive in the excision of piles
| Study group | Role | What they receive |
|---|---|---|
| ligasure | Active comparator | hemorrhoid treatment using ligasure Receives: Device: ligasure |
| conventional diathermy | Active comparator | hemorrhoid treatment using conventional diathermy Receives: Device: ligasure |
What is being measured
The primary outcome is the main question the study is designed to answer.
bleeding
occurence of bleeding after operation
Measured: 2 day postoperative
Secondary outcomes (2)
hospital stay
hospital stay after operation
Measured: 4 days
post operative itching
itching occured after operation
Measured: 2 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Oct 2026
- Study start25 Sep 2026
- Primary completion26 Mar 2027 (estimated)
- Study completion25 Apr 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HemorrhoidsStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mohamed Refaay Mohamed, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07878546
- Sponsor's protocol ID
- ligasure versus conventional d
- Status last verified
- Oct 2026
- First submitted
- 25 Sep 2026
- Last updated
- 16 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Ligasure Versus Conventional Diathermy in Hemorrhoidectomy
- ClinicalTrials.gov ID
- NCT07878546
- Acronym / sponsor ID
- ligasure versus conventional d
- Conditions
- Hemorrhoids
- Keywords
- ligasure
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 25 Sep 2026 (actual)
- Primary completion
- 26 Mar 2027 (estimated)
- Study completion
- 25 Apr 2027 (estimated)
- First posted
- 16 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
comparison study in the treatment of hemorrhoid between ligasure device and the conventional diathermy
Detailed description
comparison study between ligasure and conventional diathermy in hemorroidectomy regarding the duration of postoperatine pain, intraoperative and postoperative bleeding, early return to work, postoperative itching, and return to the normal life.
this prospective study will be conducted on 40 patients diagnosed with hemorroidectomy including all patients with symptomatic hemorrhoid comparing two groups the first group undergo hemorrhoidectomy using ligasure the second group using conventional diathermy
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| ligasure | Active comparator | Device: ligasurehemorrhoid treatment using ligasure |
| conventional diathermy | Active comparator | Device: ligasurehemorrhoid treatment using conventional diathermy |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- all patients with symptomatic hemorrhoid require hemorrhoidectomy
Key exclusion criteria (1 listed)
- presence of other rectal or anal pathology, patients with recurrent hemorrhoid, patients with other medcal or anasthetic contraindications
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ligasureusing the ligasure devive in the excision of piles | Device | conventional diathermy, ligasure |
Primary outcome
bleeding
Time frame: 2 day postoperative
occurence of bleeding after operation
2 secondary outcomes
hospital stay
Time frame: 4 days
post operative itching
Time frame: 2 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Oct 2026.
- Individual participant dataSharing planned: No
Related trials for Hemorrhoids
Not yet recruiting
Auricular Indwelling Needles Added to Diosmin/Hesperidin for Grade I-II Internal Hemorrhoids With Heat-Toxin Syndrome
Internal Haemorrhoids
Enrolling by invitation
Ultrasound-Guided Versus Landmark-Guided Pudendal Block for Post-Hemorrhoidectomy Pain
Hemorrhoids, Postoperative Pain
Not yet recruitingObservational study
Bleeding Reduction in Grade II-III Haemorrhoids Through Embolization Treatment
Hemorrhoid, Hemorrhoid Bleeding
Enrolling by invitationObservational study
Case-Specific Health Care Professional Clinical Survey for Concerto Versa™ Detachable Coils
Arteriovenous Malformation, Gastrointestinal Bleed
Recruiting
The Use of Electronic Bidets Compared to Water Rinsing After Surgery for Anal Fistula or Haemorrhoidal Disease: a Pilot Study
Anal Fistula Surgery, Anal Fistula
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
mphamed refaey, master contact
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing ligasure in people with Hemorrhoids, run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 16 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact mohamed refaey, master (01126544564, drmido2025@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
bleeding (time frame: 2 day postoperative). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2026.